【开放获取】 儿童脓疱型银屑病诊疗中国专家共识（2025版）

doi:10.35541/cjd.20240714

中华皮肤科杂志 ›› 2025, Vol. 58 ›› Issue (4): 297-306.doi: 10.35541/cjd.20240714

【开放获取】儿童脓疱型银屑病诊疗中国专家共识（2025版）

中国医师协会皮肤科医师分会儿童学组中华医学会皮肤性病学分会银屑病学组

中国医师协会皮肤科医师分会儿童学组中华医学会皮肤性病学分会银屑病学组

收稿日期:2024-12-25 修回日期:2025-01-27 发布日期:2025-04-03
通讯作者: 徐子刚；王华；王刚 E-mail:zigangxupek@163.com; huawang@hospital.cqmu.edu.cn; xjwgang@fmmu.edu.cn
基金资助:
国家重点研发计划（2023YFC2508101）；北京市医院管理中心“登峰”人才培养计划（DFL20241201）

Expert consensus on the diagnosis and treatment of pediatric pustular psoriasis in China （2025 version）

Group on Pediatric Dermatology, China Dermatologist Association; Committee on Psoriasis, Chinese Society of Dermatology

Group on Pediatric Dermatology, China Dermatologist Association; Committee on Psoriasis, Chinese Society of Dermatology

Received:2024-12-25 Revised:2025-01-27 Published:2025-04-03
Contact: Xu Zigang; Wang Hua; Wang Gang E-mail:zigangxupek@163.com; huawang@hospital.cqmu.edu.cn; xjwgang@fmmu.edu.cn
Supported by:
National Key Research and Development Program of China （2023YFC2508101）; Beijing Hospital Management Center “Dengfeng” Talent Training Program （DFL20241201）

摘要/Abstract

摘要： 【摘要】脓疱型银屑病是一种罕见的银屑病亚型，属于自身炎症性疾病范畴，临床以泛发或局限分布的红斑及无菌性脓疱为特征，泛发性脓疱型银屑病常伴有系统症状，病情反复、迁延。儿童作为高发人群，管理策略与成人有所区别。本共识综合国内外诊疗进展，结合我国现状，针对儿童脓疱型银屑病的诊断、临床亚型、疾病评估及治疗方法，共遴选了13个临床较为关注的问题，经专家组共同讨论最终形成33条循证推荐意见，旨在提升该病的规范化诊治水平，并为临床实践提供指导。

关键词: 银屑病, 儿童, 脓疱型银屑病, 诊断, 治疗, 共识

Abstract: 【Abstract】 Pustular psoriasis is a rare subtype of psoriasis, which belongs to the category of autoinflammatory diseases, clinically characterized by erythema and aseptic pustules that may be generalized or localized. Generalized pustular psoriasis is often accompanied by systemic symptoms and is known for its recurrent and prolonged nature. Management strategies for pediatric patients differ significantly from those for adults. Based on the latest Chinese and international consensus, guidelines, and considering the current diagnostic and treatment status in China, 13 key clinical issues related to diagnostic criteria for, clinical subtypes of, disease assessment, and therapeutic methods for pustular psoriasis in children were identified. Following discussions among the expert group, 33 evidence-based recommendations were developed to standardize the diagnosis and treatment of this disease, thereby providing guidance for clinical practice.

Key words: Psoriasis, Child, Pustular psoriasis, Diagnosis, Therapy, Consensus

中国医师协会皮肤科医师分会儿童学组中华医学会皮肤性病学分会银屑病学组. 【开放获取】 儿童脓疱型银屑病诊疗中国专家共识（2025版）[J]. 中华皮肤科杂志, 2025,58(4):297-306. doi:10.35541/cjd.20240714

Group on Pediatric Dermatology, China Dermatologist Association, Committee on Psoriasis, Chinese Society of Dermatology. Expert consensus on the diagnosis and treatment of pediatric pustular psoriasis in China （2025 version）[J]. Chinese Journal of Dermatology, 2025, 58(4): 297-306.doi:10.35541/cjd.20240714

参考文献 57

［1］	全国银屑病流行调查组. 全国1984年银屑病流行调查报告［J］. 中华皮肤科杂志, 1986,19（5）:253⁃261.
［2］	Feng JN, Guo JZ, Zhang Q, et al. Higher prevalence of generalized pustular psoriasis in Asia? A population⁃based study using claim data in China and a systematic review［J］. Dermatology, 2023,239（2）:195⁃205. doi: 10.1159/000528850.
［3］	Wang Z, Xiang X, Chen Y, et al. Different clinical features of pediatric generalized pustular psoriasis in patients with or without IL36RN variants［J］. Dermatology, 2023,239（2）:217⁃226. doi: 10.1159/000528753.
［4］	Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease （2022 report）［EB/OL］.（2021‑11‑22）［2024‑01‑12］. https: //goldcopd.org/.
［5］	Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations［J］. BMJ, 2008,336（7650）:924⁃926. doi: 10. 1136/bmj.39489.470347.AD.
［6］	Navarini AA, Burden AD, Capon F, et al. European consensus statement on phenotypes of pustular psoriasis［J］. J Eur Acad Dermatol Venereol, 2017,31（11）:1792⁃1799. doi: 10.1111/jdv. 14386.
［7］	Smith MP, Ly K, Thibodeaux Q, et al. Acrodermatitis continua of Hallopeau: clinical perspectives［J］. Psoriasis （Auckl）, 2019,9:65⁃72. doi: 10.2147/PTT.S180608.
［8］	Mitra D, Bhatnagar A, Kumar M. Acrodermatitis continua of hallopeau: a diagnostic challenge［J］. Indian Dermatol Online J, 2023,14（1）:91⁃93. doi: 10.4103/idoj.idoj_312_22.
［9］	《脓疱型银屑病诊疗中国专家共识（2022版）》编写委员会专家组. 脓疱型银屑病诊疗中国专家共识（2022版）［J］. 中华皮肤科杂志, 2022,55（3）:187⁃195. doi: 10.35541/cjd.20210698.
［10］	Puig L, Choon SE, Gottlieb AB, et al. Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management［J］. J Eur Acad Dermatol Venereol, 2023,37（4）:737⁃752. doi: 10.1111/jdv.18851.
［11］	Choon SE, van de Kerkhof P, Gudjonsson JE, et al. International consensus definition and diagnostic criteria for generalized pustular psoriasis from the international psoriasis council［J］. JAMA Dermatol, 2024,160（7）:758⁃768. doi: 10.1001/jamadermatol. 2024.0915.
［12］	Fujita H, Terui T, Hayama K, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP［J］. J Dermatol, 2018,45（11）:1235⁃1270. doi: 10.1111/1346⁃8138.14523.
［13］	Costanzo A, Bardazzi F, DE Simone C, et al. Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensus［J］. Ital J Dermatol Venerol, 2022,157（6）:489⁃496. doi: 10.23736/S2784⁃8671.22.07415⁃1.
［14］	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版）［J］. 中华皮肤科杂志, 2023,56（7）:573⁃625. doi: 10.35541/cjd.20220839.
［15］	Li M, Han J, Lu Z, et al. Prevalent and rare mutations in IL⁃36RN gene in Chinese patients with generalized pustular psoriasis and psoriasis vulgaris［J］. J Invest Dermatol, 2013,133（11）:2637⁃2639. doi: 10.1038/jid.2013.267.
［16］	Twelves S, Mostafa A, Dand N, et al. Clinical and genetic differences between pustular psoriasis subtypes［J］. J Allergy Clin Immunol, 2019,143（3）:1021⁃1026. doi: 10.1016/j.jaci.2018. 06.038.
［17］	Choon SE, Tok P, Wong KW, et al. Clinical profile of patients with acute generalized pustular psoriasis with and without IL36RN mutations in multi⁃ethnic Johor Bahru, Malaysia［J］. Exp Dermatol, 2023,32（8）:1263⁃1271. doi: 10.1111/exd.14776.
［18］	Menter A, Cordoro KM, Davis D, et al. Joint American Academy of Dermatology⁃National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients［J］. J Am Acad Dermatol, 2020,82（1）:161⁃201. doi: 10.1016/j.jaad.2019.08.049.
［19］	Hua S, Liu J, Fang B, et al. Novel splice site mutation at the C⁃terminal of SPINK5 cause a unique Netherton syndrome phenotype mimicking pustular psoriasis［J］. J Eur Acad Dermatol Venereol, 2023,37（1）:e113⁃e115. doi: 10.1111/jdv. 18606.
［20］	Kishimoto M, Taniguchi Y, Tsuji S, et al. SAPHO syndrome and pustulotic arthro⁃osteitis［J］. Mod Rheumatol, 2022,32（4）:665⁃674. doi: 10.1093/mr/roab103.
［21］	Chen BL, Liu QW, Dong XW, et al. Biologics for generalized pustular psoriasis: a systematic review and single⁃arm meta⁃analysis［J］. Front Immunol, 2024,15:1462158. doi: 10.3389/fimmu.2024.1462158.
［22］	Burden AD, Choon SE, Gottlieb AB, et al. Clinical disease measures in generalized pustular psoriasis［J］. Am J Clin Dermatol, 2022,23（Suppl 1）:39⁃50. doi: 10.1007/s40257⁃021⁃00653⁃0.
［23］	Bhushan M, Burden AD, McElhone K, et al. Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double⁃blind, placebo⁃controlled study［J］. Br J Dermatol, 2001,145（4）:546⁃553. doi: 10.1046/j.1365⁃2133.2001.04411.x.
［24］	Huang IH, Wu PC, Chiu HY, et al. Small⁃molecule inhibitors and biologics for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta⁃analysis［J］. Am J Clin Dermatol, 2024,25（3）:347⁃358. doi: 10.1007/s40257⁃024⁃00849⁃0.
［25］	Krueger J, Puig L, Thaçi D. Treatment options and goals for patients with generalized pustular psoriasis［J］. Am J Clin Dermatol, 2022,23（Suppl 1）:51⁃64. doi: 10.1007/s40257⁃021⁃00658⁃9.
［26］	van Geel MJ, Mul K, Oostveen AM, et al. Calcipotriol/betamethasone dipropionate ointment in mild⁃to⁃moderate paediatric psoriasis: long⁃term daily clinical practice data in a prospective cohort［J］. Br J Dermatol, 2014,171（2）:363⁃369. doi: 10.1111/bjd.12895.
［27］	Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents ⁃ short version part 1［J］. J Dtsch Dermatol Ges, 2019,17（8）:856⁃870. doi: 10.1111/ddg.13907.
［28］	Ruggiero A, Patruno C, Napolitano M, et al. Etanercept for pediatric acrodermatitis continua of Hallopeau: a case report and literature review［J］. Dermatol Ther, 2020,33（6）:e14046. doi: 10.1111/dth.14046.
［29］	Wang Z, Xiang X, Chen Y, et al. Treating paediatric acrodermatitis continua of Hallopeau with adalimumab: a case series［J］. Clin Exp Dermatol, 2022,47（1）:195⁃196. doi: 10. 1111/ced.14890.
［30］	Bachelez H, Choon SE, Marrakchi S, et al. Trial of spesolimab for generalized pustular psoriasis［J］. N Engl J Med, 2021,385（26）:2431⁃2440. doi: 10.1056/NEJMoa2111563.
［31］	Bellinato F, Gisondi P, Dattola A, et al. Spesolimab in patients with flare of generalized pustular psoriasis: a multicentre case⁃series［J］. J Eur Acad Dermatol Venereol, 2024,38（5）:e437⁃e439. doi: 10.1111/jdv.19678.
［32］	Cardenas⁃de la Garza JA, Zazueta⁃López RM, Garza⁃Elizondo AK, et al. Spesolimab treatment in a patient with generalized pustular psoriasis: a case report with 12⁃month follow⁃up and literature review［J］. Clin Exp Dermatol, 2024,49（3）:286⁃288. doi: 10.1093/ced/llad389.
［33］	Chen Y, Wang Z, Liang Y, et al. Successful treatment of pediatric generalized pustular psoriasis （GPP） with spesolimab: 5 case reports and evaluations of circulating IL⁃36 levels［J］. J Inflamm Res, 2024,17:8199⁃8206. doi: 10.2147/JIR.S485077.
［34］	Wang Y, Zhang L, Zheng J, et al. Spesolimab response in a girl with acrodermatitis continua of Hallopeau［J］. JAMA Dermatol, 2024,160（4）:476⁃477. doi: 10.1001/jamadermatol.2023.6349.
［35］	Cai L, Yan Y, Li Y, et al. Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series［J］. J Eur Acad Dermatol Venereol, 2024. doi: 10.1111/jdv.20500.
［36］	López⁃Sánchez C, Falla LM, Roé⁃Crespo E, et al. Excellent response to secukinumab in an infant with severe generalized pustular psoriasis［J］. J Dermatol, 2021,48（6）:907⁃910. doi: 10.1111/1346⁃8138.15673.
［37］	Miao C, Chen Y, Wang Z, et al. Real⁃world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis［J］. J Dermatol, 2023,50（2）:258⁃261. doi: 10.1111/1346⁃8138.16551.
［38］	Bonekamp N, Caorsi R, Viglizzo GM, et al. High⁃dose ustekinumab for severe childhood deficiency of interleukin⁃36 receptor antagonist （DITRA）［J］. Ann Rheum Dis, 2018,77（8）:1241⁃1243. doi: 10.1136/annrheumdis⁃2017⁃211805.
［39］	Chen Y, Wang Z, Miao C, et al. Etanercept: a viable treatment option for young children with generalized pustular psoriasis［J］. Pediatr Investig, 2024,8（4）:295⁃298. doi: 10.1002/ped4.12448.
［40］	Du Y, Yan Q, Chen M, et al. Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review［J］. J Dermatolog Treat, 2022,33（6）:2862⁃2868. doi: 10.1080/09546634.2022.2089327.
［41］	Hospach T, Glowatzki F, Blankenburg F, et al. Scoping review of biological treatment of deficiency of interleukin⁃36 receptor antagonist （DITRA） in children and adolescents［J］. Pediatr Rheumatol Online J, 2019,17（1）:37. doi: 10.1186/s12969⁃019⁃0338⁃1.
［42］	中华医学会皮肤性病学分会儿童学组,中国医师协会皮肤科医师分会儿童皮肤病学组. 中国儿童银屑病生物治疗专家共识（2021）［J］.中华皮肤科杂志, 2021,54（11）:943⁃950. doi: 10.35541/cjd.20210547.
［43］	Chen P, Li C, Xue R, et al. Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review［J］. J Dermatolog Treat, 2018,29（4）:353⁃363. doi: 10.1080/09546634.2017.1395798.
［44］	Srivatsa S, Boswell JS, Mully TW. Infantile pustular psoriasis: Case report of successful treatment with acitretin in a 4⁃week⁃old infant［J］. JAAD Case Rep, 2021,11:121⁃123. doi: 10.1016/j.jdcr.2021.03.038.
［45］	Gallo E, Llamas⁃Velasco M, Daudén E, et al. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin［J］. Int J Dermatol, 2013,52（12）:1610⁃1611. doi: 10.1111/j.1365⁃4632.2012.05472.x.
［46］	Wang Y, Cheng R, Lu Z, et al. Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes［J］. J Dermatol Sci, 2017,85（3）:235⁃240. doi: 10.1016/j.jdermsci.2016.11.008.
［47］	Halverstam CP, Zeichner J, Lebwohl M. Lack of significant skeletal changes after long⁃term, low⁃dose retinoid therapy: case report and review of the literature［J］. J Cutan Med Surg, 2006,10（6）:291⁃299. doi: 10.2310/7750.2006.00065.
［48］	王雅辰, 王召阳, 向欣, 等. 口服阿维A对106例儿童身高和骨骼发育影响的回顾性分析［J］. 中华皮肤科杂志, 2022,55（12）:1073⁃1077. doi: 10.35541/cjd.20220193.
［49］	Kiliç SS, Hacimustafaoğlu M, Celebi S, et al. Low dose cyclosporin A treatment in generalized pustular psoriasis［J］. Pediatr Dermatol, 2001,18（3）:246⁃248. doi: 10.1046/j.1525⁃1470.2001.018003246.x.
［50］	Kim HS, Kim GM, Kim SY. Two⁃stage therapy for childhood generalized pustular psoriasis: low⁃dose cyclosporin for induction and maintenance with acitretin/narrowband ultraviolet B phototherapy［J］. Pediatr Dermatol, 2006,23（3）:306⁃308. doi: 10.1111/j.1525⁃1470.2006.00247.x.
［51］	Takahashi M, Takeuchi M, Matsunaga K. Infant with generalized pustular psoriasis who responded to cyclosporin A therapy［J］. J Dermatol, 2015,42（9）:911⁃913. doi: 10.1111/1346⁃8138.12960.
［52］	Kumar B, Dhar S, Handa S, et al. Methotrexate in childhood psoriasis［J］. Pediatr Dermatol, 1994,11（3）:271⁃273. doi: 10.1111/j.1525⁃1470.1994.tb00602.x.
［53］	Wang Z, Chen Y, Xiang X, et al. Systemic methotrexate treatment in 42 children with severe plaque psoriasis: a retrospective study in China［J］. Dermatology, 2022,238（5）:919⁃927. doi: 10.1159/000521262.
［54］	Dogra S, Kumaran MS, Handa S, et al. Methotrexate for generalized pustular psoriasis in a 2⁃year⁃old child［J］. Pediatr Dermatol, 2005,22（1）:85⁃86. doi: 10.1111/j.1525⁃1470.2005. 22122.x.
［55］	Skrabl⁃Baumgartner A, Weger W, Salmhofer W, et al. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment［J］. Pediatr Dermatol, 2015,32（1）:e13⁃e14. doi: 10.1111/pde.12457.
［56］	Garg T, Chander R, Mittal S. Familial juvenile generalized pustular psoriasis: response to methotrexate［J］. Skinmed, 2011,9（3）:190⁃191.
［57］	Morita A, Strober B, Burden A D, et al. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares （Effisayil 2）: an international, multicentre, randomised, placebo⁃controlled trial［J］. The Lancet, 2023,402（10412）:1541⁃1551. doi: 10.1016/S0140⁃6736（23）01378⁃8.

[1]	王丽王千秋张瑞丽. 隐性梅毒研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 286-289.
[2]	卢红铮何瑞杨思燕马琳张斌. 外用噻吗洛尔联合脉冲染料激光治疗儿童丛状血管瘤1例[J]. 中华皮肤科杂志, 2026, 59(3): 253-254.
[3]	刘佳谷映桦贺小宁. 遗传性血管性水肿治疗方式与疾病负担研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 282-286.
[4]	曾莞欣文翔. 增生性瘢痕的光电治疗进展[J]. 中华皮肤科杂志, 2026, 59(3): 269-273.
[5]	范慧琳赵慧敏彭依然汪犇黄莹雪赵志祥唐言简丹. 低能量CO2点阵激光治疗玫瑰痤疮难治性持续性红斑的回顾性研究[J]. 中华皮肤科杂志, 2026, 59(3): 218-223.
[6]	朱芸王建才杨明顾菲张洪丽高莹. 755 nm皮秒激光治疗儿童咖啡牛奶斑的疗效及影响因素分析[J]. 中华皮肤科杂志, 2026, 59(3): 224-229.
[7]	夏志宽葛格. [开放获取] 白癜风激光治疗临床应用与展望[J]. 中华皮肤科杂志, 2026, 59(3): 213-217.
[8]	中华医学会皮肤性病学分会银屑病专业委员会. 伴共病的银屑病管理共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(3): 193-207.
[9]	“Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology ”解读专家组中华医学会皮肤性病学分会激光学组. [开放获取] 2025版光生物调节疗法在皮肤科的临床应用中国专家共识要点解读[J]. 中华皮肤科杂志, 2026, 59(3): 208-212.
[10]	王钧程刘洁. [开放获取] 人工智能在银屑病临床诊疗与患者管理中的应用进展[J]. 中华皮肤科杂志, 2026, 0(3): 20240061-e20240061.
[11]	郭澜晋红中. 色氨酸和精氨酸代谢对免疫反应的调控机制及其在银屑病发病中的作用研究进展[J]. 中华皮肤科杂志, 2026, 0(3): 20240377-e20240377.
[12]	许国康蔡梅. 索立德吉治疗局部晚期基底细胞癌8例临床分析[J]. 中华皮肤科杂志, 2026, 59(2): 166-169.
[13]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会中国医疗保健国际交流促进会皮肤医学分会中国罕见病联盟皮肤罕见病专业委员会. [开放获取] 佩索利单抗治疗炎症性皮肤病专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(2): 113-119.
[14]	李燕红姜琨吴卓璇章建兰方美珍刘姝婷王琳琳胡磊周小勇陈柳青陈金波. 程序性死亡受体1抑制剂相关皮肤不良反应18例临床资料分析[J]. 中华皮肤科杂志, 2026, 0(2): 20240002-e20240002.
[15]	严可心张韡宋昊徐秀莲. 纳米医学在恶性黑色素瘤诊断和治疗中的应用[J]. 中华皮肤科杂志, 2026, 59(2): 189-192.

【开放获取】儿童脓疱型银屑病诊疗中国专家共识（2025版）

Expert consensus on the diagnosis and treatment of pediatric pustular psoriasis in China （2025 version）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 57

相关文章 15

Metrics

本文评价

推荐阅读 10

【开放获取】 儿童脓疱型银屑病诊疗中国专家共识（2025版）

Expert consensus on the diagnosis and treatment of pediatric pustular psoriasis in China （2025 version）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 57

相关文章 15

Metrics

本文评价

推荐阅读 10

【开放获取】儿童脓疱型银屑病诊疗中国专家共识（2025版）